|
|
CHL Medical Partners is a venture capital firm founded in 1990, managing funds with combined committed capital of more than $300 million. CHL invests principally in start-up and early stage companies in the medical sector, defined to include: biotechnology, pharmaceuticals, genomics, proteomics, drug delivery technology, diagnostic devices, medical & surgical instrumentation, and healthcare services. CHL is looking to fund companies in the continental United States developing products or services for large and growing markets utilizing business models that offer substantial long-term competitive advantages, and to provide backing for experienced teams with successful track records in science and business management. Initial investment size ranges from $100,000 to $7.5 million, and up to $15 million over the life of the investment. The firm has grown more than 80 start up companies and is currently investing from its sixth fund, CHL Medical Partners III, L.P., a $120 million fund.
|
